Aldeyra
Price & Volume
Stats
See more52W Range | $1.07-$6.17 |
Market Cap | $94.1M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.38 |
News
See moreYahoo Finance • 2 months ago
Pre-Market Movers: TNGX, WOK, GOCO Set The Path
Yahoo Finance • 3 months ago
ALDEYRA DEADLINE FRIDAY MAY 29th: Bragar Eagel & Squire, P.C. Urgently Reminds Aldeyra Therapeutics, Inc. Investors with Large Losses to Contact the Firm Regarding Their Rights Before May 29th
Yahoo Finance • 3 months ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines – ALDX
Yahoo Finance • 3 months ago
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
About
CEO | Dr. Todd C. Brady M.D., Ph.D. |
Address | 131 Hartwell Avenue, Lexington, MA, United States, 02421 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6 |